Show
Sort by
-
- Journal Article
- A2
- open access
Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults : results from phase 1 studies
-
Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers
-
First-in-human, phase Ia/b, dose-escalation/expansion study of KRAS G12C inhibitor BI 1823911, as monotherapy and combined with anticancer therapies, in patients (pts) with advanced or metastatic solid tumours harbouring a KRAS G12C mutation
-
Phase I dose escalation study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1 in solid tumors
-
- Conference Paper
- C3
- open access
A phase 1B multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors : results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts
(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. In Journal for Immunotherapy of Cancer 9(Supplement 2). p.A562-A562 -
An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations
-
Doravirine and the potential for CYP3A-mediated drug-drug interactions
-
Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level
-
- Journal Article
- A1
- open access
KH176 under development for rare mitochondrial disease : a first in man randomized controlled clinical trial in healthy male volunteers
-
Virussen in de behandeling van kanker : oncolytische virotherapie